How often does an individual trial agree with its corresponding meta-analysis? A meta-epidemiologic study

Area of Science:

• Medical research methodology
• Evidence-based medicine
• Clinical trial analysis

Background:

• Meta-analyses offer robust conclusions but involve significant waiting times and resource allocation.
• Early trials, particularly the first, may provide timely insights, reducing delays in adopting effective interventions.
• The reliability of early trial findings compared to comprehensive meta-analyses requires investigation.

Purpose of the Study:

• To assess the concordance between the results of single clinical trials and their corresponding meta-analyses.
• To determine the accuracy of the first trial's findings in predicting meta-analysis outcomes.
• To inform strategies for reducing delays in clinical decision-making and intervention adoption.

Main Methods:

• A meta-epidemiologic study analyzed 647 meta-analyses from the Cochrane Database and major medical journals.
• Compared effect sizes of single trials (first, last, random) against their respective meta-analyses.
• Evaluated statistical significance and direction of effect for concordance.

Main Results:

• 36.0% of meta-analyses featured a statistically significant first trial.
• When the first trial was significant, 84.1% of meta-analyses showed agreement in direction and significance.
• When the first trial was insignificant, 57.9% of meta-analyses were also insignificant.

Conclusions:

• The initial findings of a single trial, especially if statistically significant, often align with meta-analysis conclusions.
• Statistically significant early trials are more reliable predictors of meta-analysis outcomes than larger trials.
• Recommending interventions based on significant first trials may be justifiable in critical situations, potentially accelerating adoption by 5-8 years.